MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, David A. Barbie, Yurie Yamamoto et al.|Cancer Research|2022Cited by 38
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancerMaria Saigí, Montse Sánchez‐Céspedes|Lung Cancer|2024Cited by 5
Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, David A. Barbie, Maria Saigí et al.|Unknown|2023Cited by 0
Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, David A. Barbie, Maria Saigí et al.|Unknown|2023Cited by 0
Supplementary Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, David A. Barbie, Maria Saigí et al.|Unknown|2023Cited by 0